William Ackman
Bill Ackman runs hedge fund Pershing Square Capital, which he started in 2003 following the dissolution of Gotham Partners.
Ackman is a value investor with an activist bent. Activist investors agitate management for changes. He owns large positions in Target (NYSE: TGT) and Borders (NYSE: BGP). He has also been involved in activist situations at Wendy's (NYSE: WEN) and McDonald's (NYSE: MCD).
Ackman proved his acumen as a short seller in 2007/2008 as short positions he held in MBIA (NYSE: MBI) and Ambac (NYSE: ABK) proved to be big winners due to the credit crunch.
In July 2008, Ackman said he was short the common stock of Fannie Mae (NYSE: FNM) and Freddie Mac (NYSE: FRE). Ackman also laid out a plan to reorganize the GSEs, which would wipe out the common shareholders.
View Older Stories View More Recent Stories
-
New Ackman Website Highlights Herbalife (HLF) Distributors That are Already Violating FTC Order
-
Herbalife (HLF) Issues Statement; 'We Understand Settlement Very Well'
-
Ackman said to maintain bet against Herbalife (HLF) shares - Bloomberg
-
Big funds push back against activist investor settlements
-
Criminal probe casts 2009 Ackman-Target boardroom brawl in new light
-
Carl Icahn Comments on Herbalife (HLF), FTC Settlement; Says Time for Co. to Consider Range of Opportunities
-
Carl Icahn Issues Statement In Response to Herbalife's (HLF) Settlement with the FTC
-
Herbalife (HLF) Enters Settlement with FTC; Board Grants Icahn Ability to Boost Stake to 34.99%
-
Herbalife and the Federal Trade Commission Reach Settlement Agreement
-
Herbalife settles pyramid scheme case with regulator, in blow to Pershing's Ackman
-
Hedge fund manager Ackman still betting against Herbalife
-
Citron's Left Keeps Changing His Position on Valeant (VRX) - Ackman
-
Bill Ackman said Valeant Pharma (VRX) won't sell Bausch & Lomb, will build out it
-
Bill Ackman expects 'very significant' Valeant Pharma (VRX) assets sales by year-end
-
Ackman Feels 'Sad' for Michael Pearson on Forced Valeant (VRX) Sale
-
Valeant Pharma (VRX) call volume and volatility up into CNBC appearance by Ackman
-
Bill Ackman Will Be on CNBC's Halftime Report Today (VRX) (HLF)
-
Have Valeant Pharma (VRX) Shareholders Finally Capitulated?
-
Ackman's Pershing Square Releases Another Video on Herbalife (HLF)
-
S&P Removes Pershing Square from CreditWatch Negative as Valeant (VRX) Stabilizes
-
Activist hedge funds dial it back in first half of 2016
-
Ackman's Pershing Square hedge fund cuts eight staffers
-
Hershey rejects $23 billion Mondelez takeover offer
-
Ackman's Pershing Square Releases Third Video on Herbalife (HLF); Notes False Claims From President’s Team Member
-
Herbalife (HLF) Litigation May Be Off Table but Damages May Be Greater than Anticipated - Height Securities
-
Ackman releases new Herbalife video; stock climbs
-
Pershing Square Holdings, Ltd. Announces Second Quarter 2016 Investor Call
-
Ackman's Pershing Square Updates on Valeant Pharma (VRX) Options Position
-
WPP AGM Trading Update
-
Leading Investors and Money Managers Exchange Strategies at Sold-Out Midwest Investment Conference
-
Fitch Affirms Pershing Square Holdings, Ltd.'s 'BBB+' Ratings; Outlook Stable
-
Ackman's Pershing Square posts losses again in May
-
Valeant's former CEO to receive $9 million severance payment, other fees
-
Valeant Pharma (VRX) Rejected Joint Takeda, TPG Takeover Approach - WSJ
-
10 Things You Need to Know About the 10-Year Anniversary of A Celebration of Heroes, Heart and Hope Gala
-
Activist investor heavyweights form new lobbying arm
-
Ackman's Pershing Square's 13F Shows Increased Stake in Restaurant Brands (QSR), Valeant (VRX), Lowered Stake in Air Products (APD), Mondelez (MDLZ), More ...
-
Following Perrigo's (PRGO) Q1 Results, Some Question Valeant's (VRX) New CEO Pick
-
Hedge fund managers give stock picks in Vegas at SALT conference
-
Key player in Pershing Square's Valeant bet leaving firm
-
Ackman's Pershing Square cuts stake in Zoetis
-
S&P Affirms Ratings on Mondelez Int'l (MDLZ); Outlook Raised to Stable
-
Best-paid U.S. hedge fund managers take home $13 billion
-
Ackman's Pershing Square seeks to sell Zoetis shares for $800 million: NYT
-
Bill Ackman to Sell $800M in Zoetis (ZTS) Stock - NYT
-
Midas touch gone, hedge fund industry's influence may be waning
-
Midas touch gone, hedge fund industry's influence may be waning
-
Midas touch gone, hedge fund industry's influence may be waning
-
Midas touch gone, hedge fund industry's influence may be waning
-
New Mexico public employees to exit Ackman's Pershing Square

